ES2093658T3 - Polipeptido ciclico con actividad antibiotica, procedimiento para su preparacion y cultivo puro de una cepa de coelomycetes. - Google Patents

Polipeptido ciclico con actividad antibiotica, procedimiento para su preparacion y cultivo puro de una cepa de coelomycetes.

Info

Publication number
ES2093658T3
ES2093658T3 ES91109856T ES91109856T ES2093658T3 ES 2093658 T3 ES2093658 T3 ES 2093658T3 ES 91109856 T ES91109856 T ES 91109856T ES 91109856 T ES91109856 T ES 91109856T ES 2093658 T3 ES2093658 T3 ES 2093658T3
Authority
ES
Spain
Prior art keywords
hydrogen
preparation
coelomycetes
strain
alkoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91109856T
Other languages
English (en)
Inventor
Iwamoto Toshiro
Fujie Akihiko
Nitta Kumiko
Tsurumi Yasuhisa
Shigematsu Nobuharu
Kasahara Chiyoshi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB909013558A external-priority patent/GB9013558D0/en
Priority claimed from GB909023666A external-priority patent/GB9023666D0/en
Priority claimed from GB919101552A external-priority patent/GB9101552D0/en
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2093658T3 publication Critical patent/ES2093658T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K11/00Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K11/02Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof cyclic, e.g. valinomycins ; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Abstract

UN COMPUESTO POLIPEPTIDO DE LA SIGUIENTE FORMULA GENERAL: DONDE R ELEVADO 1 ES HIDROGENO O UN GRUPO ACILO, R (AL CUADRADO) ES HIDROXI O ACILOXI, R ELEVADO 3 ES HIDROGENO O HIDROXISULFONILOXI, Y R ELEVADO 4 ES HIDROGENO O CARBAMOILO, CON LA SALVEDAD DE QUE (I) R (AL CUADRADO) ES ACILOXI, DONDE R ELEVADO 3 ES HIDROGENO, Y (II) R ELEVADO 1 NO ES PALMITOILO, CUANDO R (AL CUADRADO) ES HIDROXI, R ELEVADO 3 ES HIDROXISULFONILOXI Y R ELEVADO 4 ES CARBAMOILO, Y SU SAL FARMACEUTICAMENTE ACEPTABLE, PROCESOS PARA SU PREPARACION Y COMPOSICIONES FARMACEUTICAS QUE LOS COMPRENDEN. LA INVENCION TAMBIEN SE REFIERE A INTERMEDIARIOS DE LA FORMULA DONDE R ELEVADO 6 ES ALCOXI (C SUB 4-C SUB 6), ALCOXI SUPERIOR O ALQUENILOXI SUPERIOR, Y R ELEVADO 7 ES -COOH O -SO SUB 3H, O SU DERIVADO REACTIVO EN EL GRUPO CARBOXI O UNA DE SUS SALES Y DONDE R ELEVADO 8 ES HALOGENO DE 1 A 4, Y R ELEVADO 9 ES ALCOXI INFERIOR QUE TIENE UNO O MAS DE HALOGENO, ALCOXI SUPERIOR QUE TIENE UNO O MAS DE HALOGENO, O SU DERIVADO REACTIVO EN EL GRUPO CARBOXI O, UNA DE SUS SALES. LA INVENCION TAMBIEN SE REFIERE A UN CULTIVO BIOLOGICAMENTE PURO DE LA CEPA DEL MICROORGANISMO COLONICETO F -11899(FERM BP-2635).
ES91109856T 1990-06-18 1991-06-15 Polipeptido ciclico con actividad antibiotica, procedimiento para su preparacion y cultivo puro de una cepa de coelomycetes. Expired - Lifetime ES2093658T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB909013558A GB9013558D0 (en) 1990-06-18 1990-06-18 New polypeptide compound and a process for preparation thereof
GB909023666A GB9023666D0 (en) 1990-10-31 1990-10-31 Polypeptide compound and a process for preparation thereof
GB919101552A GB9101552D0 (en) 1991-01-24 1991-01-24 New polypeptide compound and a process for preparation thereof

Publications (1)

Publication Number Publication Date
ES2093658T3 true ES2093658T3 (es) 1997-01-01

Family

ID=27265144

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91109856T Expired - Lifetime ES2093658T3 (es) 1990-06-18 1991-06-15 Polipeptido ciclico con actividad antibiotica, procedimiento para su preparacion y cultivo puro de una cepa de coelomycetes.

Country Status (20)

Country Link
US (1) US5376634A (es)
EP (2) EP0462531B1 (es)
JP (1) JP3307410B2 (es)
KR (1) KR100199535B1 (es)
CN (1) CN1040541C (es)
AT (1) ATE143671T1 (es)
AU (1) AU651347B2 (es)
CA (1) CA2044746C (es)
DE (1) DE69122432T2 (es)
DK (1) DK0462531T3 (es)
ES (1) ES2093658T3 (es)
FI (1) FI912873A (es)
GR (1) GR3021780T3 (es)
HU (2) HUT58108A (es)
IE (2) IE990233A1 (es)
IL (1) IL98506A (es)
NO (1) NO912347L (es)
OA (1) OA09369A (es)
PT (1) PT98023B (es)
RU (1) RU2108342C1 (es)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8925593D0 (en) * 1989-11-13 1990-01-04 Fujisawa Pharmaceutical Co Fr901379 substance and preparation thereof
US5386009A (en) * 1990-03-19 1995-01-31 Merck & Co. Inc. Lipopeptide derivatives
US5330973A (en) * 1990-03-19 1994-07-19 Merck & Co., Inc. Lipopeptide derivatives
IL98506A (en) 1990-06-18 1996-09-12 Fujisawa Pharmaceutical Co Peptides, of antibiotics, processes for their preparation and pharmaceutical preparations containing them
US5428009A (en) * 1990-07-16 1995-06-27 Merck & Co., Inc. Lipopeptide derivatives
USH1638H (en) * 1990-11-08 1997-03-04 Furuta; Takahisa Use of the polypeptide compound
US5385884A (en) * 1991-08-27 1995-01-31 Merck & Co. Inc. Lipopeptide derivatives
US5965525A (en) * 1992-03-19 1999-10-12 Eli Lilly And Company Cyclic peptide antifungal agents
US6384013B1 (en) 1992-03-19 2002-05-07 Eli Lilly And Company Cyclic peptide antifungal agents and process for preparation thereof
US6743777B1 (en) 1992-03-19 2004-06-01 Eli Lilly And Company Cyclic peptide antifungal agents and process for preparation thereof
EP0697879A4 (en) * 1993-05-04 1998-01-14 Merck & Co Inc AMINOALKYL ETHERS OF CYCLOHEXAPEPTIDYLE
IL109615A (en) * 1993-05-17 2000-12-06 Fujisawa Pharmaceutical Co Cyclic polypeptide derivatives processes for the preparation thereof and pharmaceutical compositions containing the same
US5516757A (en) * 1994-09-16 1996-05-14 Merck & Co., Inc. Semi-synthetic lipopeptides, compositions containing said lipopeptides, and methods of use
ATE229541T1 (de) 1994-10-07 2002-12-15 Fujisawa Pharmaceutical Co Zyklische hexapeptide mit antibiotischer aktivität
US5516756A (en) * 1994-10-31 1996-05-14 Merck & Co., Inc. Aza cyclohexapeptide compounds
WO1996022784A1 (en) * 1995-01-26 1996-08-01 Merck & Co., Inc. Novel antifungal cyclohexapeptides
US5646111A (en) * 1995-04-07 1997-07-08 Eli Lilly And Company Cyclic peptide antifungal Agents
US5618787A (en) * 1995-05-26 1997-04-08 Eli Lilly And Company Cyclic peptide antifungal agents
US5652213A (en) * 1995-05-26 1997-07-29 Eli Lilly And Company Cyclic peptide antifungal agents
US5786325A (en) * 1995-05-26 1998-07-28 Eli Lilly And Company Cyclic peptide antifungal agents and methods of making and using
US5629290A (en) * 1995-05-26 1997-05-13 Eli Lilly And Company Cyclic peptide antifungal agents
US5629289A (en) * 1995-07-25 1997-05-13 Eli Lilly And Company Cyclic peptide antifungal agents
WO1997047738A1 (fr) * 1996-06-13 1997-12-18 Fujisawa Pharmaceutical Co., Ltd. Acylase des lipopeptides cycliques
AUPO371596A0 (en) * 1996-11-19 1996-12-12 Fujisawa Pharmaceutical Co., Ltd. New compound
TR200003064T2 (tr) 1998-02-09 2001-02-21 Fujisawa Pharmaceutical Co; Ltd. Yeni bileşik
KR100388120B1 (ko) * 1998-05-11 2003-06-18 다케다 야쿠힌 고교 가부시키가이샤 저혈당 및 저지질혈 활성을 갖는 옥시이미노알칸산 유도체
JP2002528388A (ja) 1998-08-20 2002-09-03 イーライ リリー アンド カンパニー 環改変された環状ペプチドアナログ
DK1137663T3 (da) 1998-12-09 2007-01-08 Lilly Co Eli Oprensning af Echinocandin-cyclopeptidforbindelser
IL145188A0 (en) 1999-03-03 2002-06-30 Lilly Co Eli Processes for making pharmaceutical oral ecb formulations and compositions
JP4063497B2 (ja) 1999-03-03 2008-03-19 イーライ リリー アンド カンパニー エキノカンジンアンモニウム塩結晶の形成およびアニオン交換
ES2204548T3 (es) 1999-03-03 2004-05-01 Eli Lilly And Company Complejos de equinocandina/carbohidrato.
EP1156782B1 (en) 1999-03-03 2005-05-04 Eli Lilly And Company Echinocandin pharmaceutical formulations containing micelle-forming surfactants
AUPP999799A0 (en) 1999-04-27 1999-05-20 Fujisawa Pharmaceutical Co., Ltd. New compound
TWI233805B (en) * 1999-07-01 2005-06-11 Fujisawa Pharmaceutical Co Stabilized pharmaceutical composition in lyophilized form as antifungal agent
US20040082757A1 (en) * 2001-02-26 2004-04-29 Katsuhiko Ito Echinocandin derivatives, pharmaceutical compositions containing same and use thereof as drugs
KR20010098986A (ko) * 2001-07-27 2001-11-09 김종군 바르는 단열재(temp-coat)
US6991800B2 (en) 2002-06-13 2006-01-31 Vicuron Pharmaceuticals Inc. Antifungal parenteral products
US7459290B1 (en) 2004-03-30 2008-12-02 Iowa State University Research Foundation, Inc. Methods of using functional 30S subunits
WO2010064219A1 (en) 2008-12-04 2010-06-10 Ranbaxy Laboratories Limited Process for the preparation of a novel intermediate for caspofungin
JP6000254B2 (ja) * 2010-09-29 2016-09-28 上海天偉生物制薬有限公司 環状リポペプチド化合物又はその塩の精製方法
JP6000255B2 (ja) * 2010-09-30 2016-09-28 上海天偉生物制薬有限公司 環状リポペプチド化合物又はその塩の精製方法
CN102533551B (zh) * 2010-12-15 2013-10-09 上海天伟生物制药有限公司 一种肽类抗生素的高产菌株及其制备方法和用途
CN102618604B (zh) * 2011-01-31 2014-09-03 上海天伟生物制药有限公司 一种环脂肽化合物的制备方法
AU2012244435B2 (en) 2011-04-20 2017-06-15 Xellia Pharmaceuticals Aps Method for purification of Micafungin
CN102627689B (zh) * 2012-03-30 2014-08-06 上海天伟生物制药有限公司 一种环肽类化合物的水合物及其制备方法和用途
CN102627688B (zh) * 2012-03-30 2014-12-31 上海天伟生物制药有限公司 一种高纯度环肽化合物及其制备方法和用途
CN102659930B (zh) * 2012-03-30 2014-04-23 上海天伟生物制药有限公司 一种高纯度环肽类物质的晶体及其制备方法和用途
CN103387975A (zh) * 2012-05-11 2013-11-13 上海天伟生物制药有限公司 一种固定化环脂肽酰基转移酶及其制备方法和用途

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4293489A (en) * 1979-12-13 1981-10-06 Eli Lilly And Company Derivatives of A-30912A nucleus
CA1182812A (en) * 1979-12-13 1985-02-19 Bernard J. Abbott Process for the preparation of derivatives of cyclic peptide nuclei
CA1159450A (en) * 1979-12-13 1983-12-27 Manuel Debono Process for the preparation of derivatives of cyclic peptide nuclei
US4293482A (en) * 1979-12-13 1981-10-06 Eli Lilly And Company A-30912A Nucleus
US4293484A (en) * 1979-12-13 1981-10-06 Eli Lilly And Company Derivatives of A-30912H nucleus
US4293488A (en) * 1979-12-13 1981-10-06 Eli Lilly And Company Derivatives of A-30912B nucleus
EP0209061B1 (de) * 1985-07-17 1994-01-12 Hoechst Aktiengesellschaft Neue Polypeptide mit blutgerinnungshemmender Wirkung, Verfahren zu deren Herstellung bzw. Gewinnung, deren Verwendung und diese enthaltende Mittel
EP0311193B1 (en) * 1987-10-07 1993-12-01 Merck & Co. Inc. Antifungal fermentation product
DK173802B1 (da) * 1988-09-12 2001-11-05 Merck & Co Inc Præparat til behandling af Pneumocystis carinii infeksioner og anvendelse af et cyclohexapeptid til fremstilling af et lægemiddel mod Pneumocystis carinii infektioner
AU6645790A (en) * 1989-10-18 1991-05-16 City Of Hope Stable mammalian cell lines that express aromatase
GB8925593D0 (en) * 1989-11-13 1990-01-04 Fujisawa Pharmaceutical Co Fr901379 substance and preparation thereof
US5330973A (en) * 1990-03-19 1994-07-19 Merck & Co., Inc. Lipopeptide derivatives
US5386009A (en) * 1990-03-19 1995-01-31 Merck & Co. Inc. Lipopeptide derivatives
IL98506A (en) 1990-06-18 1996-09-12 Fujisawa Pharmaceutical Co Peptides, of antibiotics, processes for their preparation and pharmaceutical preparations containing them
EP0486011A3 (en) * 1990-11-16 1992-07-15 Fujisawa Pharmaceutical Co., Ltd. Pharmaceutical composition against pneumocystis carinii

Also Published As

Publication number Publication date
JPH04352799A (ja) 1992-12-07
AU651347B2 (en) 1994-07-21
PT98023A (pt) 1992-03-31
RU2108342C1 (ru) 1998-04-10
IE990233A1 (en) 2000-11-15
OA09369A (en) 1992-09-15
CA2044746A1 (en) 1991-12-19
GR3021780T3 (en) 1997-02-28
FI912873A (fi) 1991-12-19
HU912014D0 (en) 1991-12-30
NO912347D0 (no) 1991-06-17
DE69122432T2 (de) 1997-03-20
HU211740A9 (en) 1995-12-28
EP0729974A1 (en) 1996-09-04
FI912873A0 (fi) 1991-06-14
ATE143671T1 (de) 1996-10-15
DE69122432D1 (de) 1996-11-07
CN1040541C (zh) 1998-11-04
HUT58108A (en) 1992-01-28
KR100199535B1 (ko) 1999-06-15
JP3307410B2 (ja) 2002-07-24
IE912046A1 (en) 1991-12-18
AU7843591A (en) 1992-01-16
US5376634A (en) 1994-12-27
DK0462531T3 (da) 1996-11-18
EP0462531B1 (en) 1996-10-02
PT98023B (pt) 1998-11-30
CA2044746C (en) 2001-08-07
IL98506A0 (en) 1992-07-15
IL98506A (en) 1996-09-12
CN1059729A (zh) 1992-03-25
KR920000788A (ko) 1992-01-29
EP0462531A2 (en) 1991-12-27
EP0462531A3 (en) 1992-11-04
NO912347L (no) 1991-12-19

Similar Documents

Publication Publication Date Title
ES2093658T3 (es) Polipeptido ciclico con actividad antibiotica, procedimiento para su preparacion y cultivo puro de una cepa de coelomycetes.
NO904904D0 (no) Fremgangsmaate for fremstilling av en polypeptidforbindelse
AU6199494A (en) New polypeptide compound and a process for preparation thereof
EP0215654A3 (en) Macrolide antibiotics and their preparation
ES2002731A6 (es) Un metodo de preparacion de nuevos antibioticos peptidicos y su empleo como agentes antimicrobianos y antitumorales.
KR930000537A (ko) 글리코펩티드, 이의 제조방법 및 이의 용도
EP0350811A3 (en) Enzymatic resolution process
MY111439A (en) Thymosin alpha 1 derivatives
HUT46945A (en) Process for producing new azoxy derivatives and pharmaceutical compositions containing them as active components
ES2134971T3 (es) Derivado de acido octahidro-2-naftaleno-carboxilico, su produccion y uso.
ATE113608T1 (de) Antibiotikum.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 462531

Country of ref document: ES